MORROW GEORGE J - 30 Oct 2026 Form 4 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Reporting relationship: Director
Issuer ticker: NBIX
Reported as of: 30 Oct 2026
Net transaction value: -$2,335,982
SEC form: 4
Accepted by SEC: 03 Nov 2026, 18:52:00 UTC
Prior SEC filing: 29 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Darin Lippoldt, Attorney-in-Fact

Filing notes and source

Key filing fact

MORROW GEORGE J filed Form 4 for NEUROCRINE BIOSCIENCES INC (NBIX) on 03 Nov 2026.

Key facts

This page summarizes MORROW GEORGE J's Form 4 filing for NEUROCRINE BIOSCIENCES INC (NBIX).
18 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 03 Nov 2026, 18:52.

Change

Previous filing in this sequence was filed on 29 May 2026.
Current net transaction value: -$2,335,982.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001068754 Primary reporting owner

MORROW GEORGE J

Relationship: Director
Address: 6027 EDGEWOOD BEND CT., SAN DIEGO
Signature: /s/ Darin Lippoldt, Attorney-in-Fact
Signature date: 03 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NBIX transaction

Common Stock

Options Exercise

Transaction value
Shares: +300
Change %: +2.9%
Price: $53.64^*
Shares after: 10,686
Date: 30 Oct 2026
Ownership: Direct

NBIX transaction

Common Stock

Sale

Transaction value: -$44,700
Shares: -300
Change %: -2.8%
Price: $149.00
Shares after: 10,386
Date: 30 Oct 2026
Ownership: Direct
Footnotes: F1

NBIX transaction

Common Stock

Options Exercise

Transaction value
Shares: +7,500
Change %: +72%
Price: $53.64^*
Shares after: 17,886
Date: 02 Nov 2026
Ownership: Direct

NBIX transaction

Common Stock

Sale

Transaction value: -$275,453
Shares: -1,900
Change %: -11%
Price: $144.98
Shares after: 15,986
Date: 02 Nov 2026
Ownership: Direct
Footnotes: F1, F2

NBIX transaction

Common Stock

Sale

Transaction value: -$627,194
Shares: -4,300
Change %: -27%
Price: $145.86
Shares after: 11,686
Date: 02 Nov 2026
Ownership: Direct
Footnotes: F1, F3

NBIX transaction

Common Stock

Sale

Transaction value: -$190,783
Shares: -1,300
Change %: -11%
Price: $146.76
Shares after: 10,386
Date: 02 Nov 2026
Ownership: Direct
Footnotes: F1, F4

NBIX transaction

Common Stock

Options Exercise

Transaction value
Shares: +7,200
Change %: +69%
Price: $53.64^*
Shares after: 17,586
Date: 03 Nov 2026
Ownership: Direct

NBIX transaction

Common Stock

Sale

Transaction value: -$15,818
Shares: -100
Change %: -0.57%
Price: $158.18
Shares after: 17,486
Date: 03 Nov 2026
Ownership: Direct
Footnotes: F1

NBIX transaction

Common Stock

Sale

Transaction value: -$16,205
Shares: -100
Change %: -0.57%
Price: $162.05
Shares after: 17,386
Date: 03 Nov 2026
Ownership: Direct
Footnotes: F1

NBIX transaction

Common Stock

Sale

Transaction value: -$98,225
Shares: -600
Change %: -3.5%
Price: $163.71
Shares after: 16,786
Date: 03 Nov 2026
Ownership: Direct
Footnotes: F1, F5

NBIX transaction

Common Stock

Sale

Transaction value: -$201,971
Shares: -1,226
Change %: -7.3%
Price: $164.74
Shares after: 15,560
Date: 03 Nov 2026
Ownership: Direct
Footnotes: F1, F6

NBIX transaction

Common Stock

Sale

Transaction value: -$150,461
Shares: -908
Change %: -5.8%
Price: $165.71
Shares after: 14,652
Date: 03 Nov 2026
Ownership: Direct
Footnotes: F1, F7

NBIX transaction

Common Stock

Sale

Transaction value: -$244,492
Shares: -1,466
Change %: -10%
Price: $166.77
Shares after: 13,186
Date: 03 Nov 2026
Ownership: Direct
Footnotes: F1, F8

NBIX transaction

Common Stock

Sale

Transaction value: -$251,587
Shares: -1,500
Change %: -11%
Price: $167.72
Shares after: 11,686
Date: 03 Nov 2026
Ownership: Direct
Footnotes: F1, F9

NBIX transaction

Common Stock

Sale

Transaction value: -$219,092
Shares: -1,300
Change %: -11%
Price: $168.53
Shares after: 10,386
Date: 03 Nov 2026
Ownership: Direct
Footnotes: F1, F10

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NBIX transaction Derivative

Non-Qualified Stock Option

Options Exercise

Transaction value
Shares: -300
Change %: -2%
Price: $0.000000^*
Shares after: 14,700
Date: 30 Oct 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 300
Exercise price: $53.64
Footnotes: F11

NBIX transaction Derivative

Non-Qualified Stock Option

Options Exercise

Transaction value
Shares: -7,500
Change %: -51%
Price: $0.000000^*
Shares after: 7,200
Date: 02 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $53.64
Footnotes: F11

NBIX transaction Derivative

Non-Qualified Stock Option

Options Exercise

Transaction value
Shares: -7,200
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 03 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,200
Exercise price: $53.64
Footnotes: F11

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 11 footnotes

Footnote F1

The dispositions reported in this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2026. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

Footnote F2

Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $144.32 to $145.28. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Footnote F3

Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $145.35 to $146.34. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Footnote F4

Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $146.38 to $147.26. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Footnote F5

Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $163.21 to $164.01. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Footnote F6

Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $164.22 to $165.20. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Footnote F7

Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $165.26 to $166.24. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Footnote F8

Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $166.26 to $167.20. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Footnote F9

Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $167.27 to $168.18. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Footnote F10

Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $168.27 to $169.10. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Footnote F11

The option was granted May 22, 2017 and vested in 12 equal monthly installments beginning June 22, 2017. These options were scheduled to expire on May 22, 2027.